Overall, these findings indicate that lncRNA-TPM3P9 is able to be translated into the new microprotein TPM3P9, which is abnormally upregulated in ccRCC and associated with poor prognosis. This evidence concerns the gene TPM3P9 and nonpapillary renal cell carcinoma.